Discover 3,005 paid clinical trials in Riverside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,005
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
Location: Los Angeles CA, La Jolla CA, Stanford CA, Seattle WA,
Sponsor: XVIVO Perfusion
Sex: All
Age: 18+
Code: NCT06895070
Recruiting
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
for
Hemophagocytic Lymphohistiocytoses
Location: Irvine CA, San Diego CA, San Francisco CA,
Sponsor: Jerry Lee, MD, MSc, MPhil
Sex: All
Age: 18+
Code: NCT06160791
Phase 2, Recruiting
Ceribell Delirium Monitor Outcomes Pilot Study
for
Delirium in the Intensive Care Unit
Location: Irvine CA
Sponsor: Ceribell Inc.
Sex: All
Age: 18+
Code: NCT07449416
Recruiting
AFO Prescription to Optimize Post-Stroke Function
for
Ankle Foot Orthosis (AFO), Stroke Patients,
Location: Downey CA, Houston TX, Jacksonville FL, Charleston SC
Sponsor: University of Texas at Austin
Sex: All
Age: 18+
Code: NCT06692686
Recruiting
I CAN DO Surgical ACP
for
Surgical Advanced Care Planning
Location: Irvine CA, San Francisco CA, Minneapolis MN
Sponsor: University of California, San Francisco
Sex: All
Age: 65+
Code: NCT06090552
Recruiting
Featured
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Beverly Hills CA, Denver CO, Seattle WA, St Louis MO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06896916
Phase 1, Recruiting
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
for
Intracranial Meningioma
Location: Irvine CA, La Jolla CA, Houston TX, Iowa City IA,
Sponsor: RTOG Foundation, Inc.
Sex: All
Age: 18+
Code: NCT06955169
Phase 2, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Los Angeles CA, Bullhead City AZ, Fort Worth TX,